首页 > 市场调查报告书 > 製药

基因治疗学和RNAi

市场调查报告书

商品编码

1608704

无细胞蛋白表达市场：按产品类型、按应用、按最终用户、按地区

Cell-free Protein Expression Market, By Product Type, By Application, By End User, By Geography

出版日期: 2024年11月11日 | 出版商:

Coherent Market Insights | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

简介目录

无细胞蛋白表现市场预计到 2024 年将达到 3.181 亿美元，预计到 2031 年将达到 5.127 亿美元，2024 年至 2031 年复合年增长率为 7.1%。

报告范围		报告详情
基准年	2023年	2024年市场规模	3.181 亿美元
实际资料	2019-2023	预测期	2024-2031
预测 2024-2031 年复合年增长率：	7.10%	2031年价值预测	5.127 亿美元

图：2024 年按地区分類的无细胞蛋白质表现市场占有率(%)

无细胞蛋白质表现（也称为试管内蛋白质合成）利用来自细菌、酵母菌和其他细胞的细胞成分（例如核醣体、胺基酸、DNA/mRNA 和其他因子）在试管内。过程。无细胞系统不是使用细菌或酵母等活生物体来生产蛋白质，而是允许蛋白质在受控环境中透过活细胞外的转录和翻译等机製表达，提供灵活的编程套件。这允许使用无细胞方法生产对宿主细胞有毒或难以在细胞内表达的蛋白质。由于生物製药、合成生物学和基础生物学研究等行业对快速、可扩展且经济高效的蛋白质生产技术的需求不断增加，无细胞蛋白质表现市场正在不断增长。

市场动态：

推动无细胞蛋白表现市场成长的关键因素是生物医学研究和治疗药物开发中对功能性天然人类蛋白质的需求不断增加。无细胞系统可以快速、可扩展且经济地评估多种蛋白质变体，无需对活细胞进行基因操作，从而加速采用传统的原核和真核表达方法。然而，与细胞裂解液製备和反应条件优化相关的技术挑战阻碍了该技术的广泛商业化。开发针对各种蛋白质类别进行最佳化的稳健、标准化、无细胞平台将有助于解决现有缺点并扩展应用。连续交换无细胞 (CECF) 方法和将无细胞表达与下游分析相结合的整合系统的持续部署为市场带来了利润丰厚的机会。

本研究的主要特点

该报告详细分析了全球无细胞蛋白表达市场，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。

它还阐明了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球无细胞蛋白表达市场的主要企业。

主要公司有 Thermo Fisher Scientific, Inc.、Takara Bio Inc.、Merck KGaA、New England Biolabs、Bio-Rad Laboratories, Inc.、Promega Corporation、Jena Bioscience GmbH、GeneCopoeia, Inc.、CellFree Sciences Co. Ltd。 GmbH、Moderna Therapeutics、Biotechrabbit GmbH 和Profacgen。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球无细胞蛋白表达市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球无细胞蛋白表达市场的各种策略矩阵，将促进相关人员的决策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	318.1 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	7.10%	2031 Value Projection:	512.7 Mn

Cell-free protein expression, also known as in vitro protein synthesis, is a biotechnological process that utilizes cellular components like ribosomes, amino acids, DNA/mRNA, and other factors from bacteria, yeast, or other cells to produce active proteins outside living cells in a test tube. Rather than using live organisms like bacteria or yeast to produce proteins, cell-free systems provide a flexible toolkit to program expression through mechanisms like transcription and translation outside living cells in an easily controlled environment. This allows proteins which are toxic to the host cell or difficult to express intracellularly to be produced using cell-free methods. The cell-free protein expression market is growing due to the increasing demand for rapid, scalable, and cost-effective techniques for protein production across industries like biopharmaceuticals, synthetic biology, and basic biological research.

Market Dynamics:

The major drivers fueling growth in the cell-free protein expression market include rising demand for functional and native human proteins in biomedical research and therapeutics development. Cell-free systems allow rapid, scalable, and economical evaluation of multiple protein variants without genetic manipulation of live cells which is accelerating its adoption over traditional prokaryotic and eukaryotic expression methods. However, technical challenges related to optimizing cell lysate preparation and reaction conditions restrain the wider commercialization of this technique. Development of robust, standardized cell-free platforms optimized for different protein classes can help address existing shortcomings and expand applications. Growing deployment of continuous-exchange cell-free (CECF) methods and integrated systems coupling cell-free expression with downstream analysis presents lucrative opportunities in the market.

Key Features of the Study:

This report provides in-depth analysis of the global cell-free protein expression market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cell-free protein expression market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Takara Bio Inc., Merck KGaA, New England Biolabs, Bio-Rad Laboratories, Inc., Promega Corporation, Jena Bioscience GmbH, GeneCopoeia, Inc., CellFree Sciences Co., Ltd., Cube Biotech GmbH, Moderna Therapeutics, Biotechrabbit GmbH, and Profacgen

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global cell-free protein expression market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell-free protein expression market

Market Segmentation

By Product Type Insights (Revenue, USD Mn, 2019 - 2031)
- Expression Systems
- Insect Cells Cell-free Protein Expression System
- coli Cell-free Protein Expression System
- Rabbit Reticulocytes Cell-free Protein Expression System
- Others
- Reagents
- Others (Vectors, yeast cell extracts, etc.)
By Application Insights (Revenue, USD Mn, 2019 - 2031)
- Enzyme Engineering
- High Throughput Production
- Protein-Protein interaction
- Others (High Throughput Production, etc.)
By End User Insights (Revenue, USD Mn, 2019 - 2031)
- Biotechnological Companies
- Pharmaceutical Companies
- Contract Research Organizations
- Others (Academic and Research Institutes, etc.)
Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Thermo Fisher Scientific, Inc.
- Takara Bio Inc.
- Merck KGaA
- New England Biolabs
- Bio-Rad Laboratories, Inc.
- Promega Corporation
- Jena Bioscience GmbH
- GeneCopoeia, Inc.
- CellFree Sciences Co., Ltd.
- Cube Biotech GmbH
- Moderna Therapeutics
- Biotechrabbit GmbH
- Profacgen

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Cell-free Protein Expression Market, By Product Type
- Cell-free Protein Expression Market, By Application
- Cell-free Protein Expression Market, By End User
- Cell-free Protein Expression Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Market Trends
Key Developments

4. Global Cell-free Protein Expression Market, By Product Type, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Expression Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Insect Cells Cell-free Protein Expression System
coli Cell-free Protein Expression System
Rabbit Reticulocytes Cell-free Protein Expression System
Others
Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others (Vectors, yeast cell extracts, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Cell-free Protein Expression Market, By Application, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Enzyme Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
High Throughput Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Protein-Protein interaction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others (High Throughput Production, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Cell-free Protein Expression Market, By End User, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biotechnological Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others (Academic and Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Cell-free Protein Expression Market, By Region, 2019 - 2031, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
New England Biolabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jena Bioscience GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GeneCopoeia, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CellFree Sciences Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cube Biotech GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Moderna Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotechrabbit GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Profacgen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

无细胞蛋白表达市场：按产品类型、按应用、按最终用户、按地区